4//SEC Filing
Rosenblum Mark J 4
Accession 0001615219-23-000004
CIK 0001615219other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:35 PM ET
Size
4.9 KB
Accession
0001615219-23-000004
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Common Stock
2023-01-03+8,000→ 15,419 total
Footnotes (1)
- [F1]Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 25% of the shares of restricted stock will vest on January 2, 2024, and 1/36 of the remaining shares of restricted stock will vest on monthly anniversary thereafter.
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001329154
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:35 PM ET
- Size
- 4.9 KB